Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Postgrad Med J. 2009 May;85(1003):251-6. doi: 10.1136/pgmj.2008.073213.

Spurious and counterfeit drugs: a growing industry in the developing world.

Author information

  • 1Department of Pharmacology, Government Medical College, Chandigarh, India. csgautam_06@yahoo.co.in

Abstract

Spread of spurious/counterfeit/substandard drugs is a modern day menace which has been recognised internationally, especially so in developing countries. The problem assumes added significance in view of rapid globalisation. The market of spurious and counterfeit drugs is a well-organised, white collar crime. Poverty, high cost of medicines, lack of an official supply chain, legislative lacunae, easy accessibility to computerised printing technology, ineffective law enforcement machinery, and light penalties provide the counterfeiters with an enormous economic incentive without much risk. The consequences of the use of such medicines may vary from therapeutic failure to the occurrence of serious adverse events and even death. Proper drug quality monitoring, enforcement of laws and legislation, an effective and efficient regulatory environment, and awareness and vigilance on part of all stakeholders can help tackle this problem.

PMID:
19520877
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk